PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 15 Issue 4

The Trial Master File (TMF)

IPI speaks with Aaron Grant, VP of Solutions Consulting at Phlexglobal, (a PharmaLex Company)on how managing the TMF requires following best practice and taking adva...
Continue Reading →
Volume 14 Issue 4

EU CTR: Final Countdown, What You Need to Know

The end of the transition period is imminent. How can clinical trial sponsors and CROs ease the transition to CTIS? Soon, the one-year transition period of the EU...
Continue Reading →
News

Opdivo plus chemo improves event-free survival in NSCLC patients

Bristol Myers Squibb (BMS) has announced that its PD-1 inhibitor Opdivo (nivolumab) plus chemotherapy improved event-free survival in a Phase III trial in patients w...
Continue Reading →
News

AZ announces US fast track designation for IL-5 inhibitor Fasenra

AstraZeneca’s IL-5 inhibitor Fasenra (benralizumab) has received a fast-track designation from the US Food and Drug Administration for the treatment of eosinoph...
Continue Reading →
News

UK trial to evaluate existing drugs for secondary breast cancer

A new UK-based clinical trial will evaluate existing cancer drugs as potential treatments for women living with metastatic breast cancer. The study, led by Profes...
Continue Reading →
News

Promising early results for new ovarian cancer drug combo

Results from an early-stage clinical trial found a new combination of target drugs could provide a new treatment option for treatment-resistant advanced ovarian canc...
Continue Reading →
News

Enhertu improves progression-free survival in breast cancer trial

Positive topline results from a Phase III trial for Daiichi Sankyo and AstraZeneca’s breast cancer drug Enhertu have shown that the HER2-directed antibody drug conju...
Continue Reading →
News

PCI Clinical Services Gets Green Light to Begin Operations in Expansion of European Site

Leading international pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has completed validation and received licensing of its newly expanded ...
Continue Reading →
News

Plasticell and Anthony Nolan to partner in clinical trials of ex vivo expanded cord blood stem cells

Plasticell, a developer of innovative stem cell technologies and cell therapies, today announced it will collaborate with Anthony Nolan, a leading research organisat...
Continue Reading →
News

Sanofi and Principia agree to develop MS drug candidate

Sanofi will develop Principia Biopharma Inc.'s experimental oral treatment that shows promise in multiple sclerosis (MS) and, potentially, other central nervous syst...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026